Fig. 4From: Molecular characterization of breast cancer cell lines through multiple omic approachesKinome results for the (a) fibroblast growth factor receptor (FGFR) and (b) ephrin (EphA/B) signaling pathways. The analysis was carried out as detailed for “Fig. 3”. HER2amp human epidermal growth factor receptor 2-amplified, ER estrogen receptor, TNBC triple negative breast cancerBack to article page